// App-Quantinova.ai

e12532 : Usage and factors associated with adjuvant bisphosphonate therapy among postmenopausal women diagnosed with early-stage breast cancer.

Researchers

Presenter

  • Veera Durga Sravanthi Panuganty

Principal Investigators

  • Suganija Lakkunarajah

  • Sumugan Shanmuganathan

  • Morgan Black

  • Sharifa Nasreen

  • Igor Karp

  • Theodore A. Vandenberg

  • Jacques Raphael

  • Ricardo Fernandes

  • Phillip S. Blanchette

Medical Centers

  • Department of Oncology, Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University and London Regional Cancer Program, London, ON, Canada

  • Department of Medicine, Schulich School of Medicine, Western University, London, ON, Canada,

  • Department of Epidemiology and Biostatistics, Western University, London, ON, Canada

  • London Regional Cancer Program, Western University, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Progesterone receptor

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved